Fintech Firm Blend Labs Seeks US$360 Million In IPO

Blend Labs Inc. announced this morning the launch of its initial public offering on the New York Stock Exchange. The company will be offering 20.0 million Class A stocks on the big board under the symbol “BLND”.

The offering price is expected to be between US$16.00 to US$18.00 per share for potential total aggregate proceeds of up to US$360.0 million. The financial software company also gave the underwriters a 30-day option to purchase an additional 3,000,000 common shares.

In the prospectus filed, the San Francisco-based fintech company recorded US$31.9 million in revenue and a US$27.1 million net loss for Q1 2021. The company also raised US$300.0 million in its last round of funding in January 2021, putting the company’s valuation at US$3.3 billion. The proposed public offering seeks to bring this up to US$3.95 billion.

Goldman Sachs & Co., Allen & Company, and Wells Fargo Securities are all managing the offering as lead underwriters. 


Information for this briefing was found via Blend. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Gold Trade Is Shifting From Margins to Growth | Geordie Mark – Blue Jay Gold

CopAur Minerals – This PEA Has A Mine Life of What?!

Ontario’s Fast Track to Silver Production Is Starting to Matter | Frank Basa – Nord Precious Metals

Recommended

Crossroads Gold Begins 2026 Exploration at Pambula, Reports Gold In Soil Up to 24.6 g/t

Questcorp Kicks Off Fully Funded Phase 2 Drilling at La Union

Related News

Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq...

Tuesday, January 4, 2022, 02:36:00 PM

Robinhood Creating Platform to Allow Amateur Investors to Buy IPOs, Including its Own

While still brushing off daytrader anguish and congressional scrutiny after its decision to pause trading...

Saturday, March 27, 2021, 11:21:00 AM

Biotech Firm OKYO Pharma Closes US$2.5 Million IPO

Biotech firm OKYO Pharma Limited (Nasdaq: OKYO) closed on Thursday its initial public offering on...

Saturday, May 21, 2022, 05:12:00 PM

Restaurant Operator Yoshiharu Prices Upsized US$11.8 Million IPO

Restaurant operator Yoshiharu Global Co. (Nasdaq: YOSH) started trading on the Nasdaq Capital Market on...

Friday, September 9, 2022, 02:22:00 PM

Tech SPAC Denali Capital Acquisition Prices US$75 Million IPO

Special purpose acquisition company Denali Capital Acquisition Corp. (Nasdaq: DECAU) started trading publicly on the...

Friday, April 8, 2022, 02:19:00 PM